PON1 activities and oxidative markers of LDL in patients with angiographically proven coronary artery disease
- 30 September 2003
- journal article
- clinical trial
- Published by Elsevier in International Journal of Cardiology
- Vol. 91 (1), 43-51
- https://doi.org/10.1016/s0167-5273(02)00595-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Human Serum ParaoxonaseGeneral Pharmacology: The Vascular System, 1998
- Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.Journal of Clinical Investigation, 1998
- Increased Oxidation of LDL in Patients With Coronary Artery Disease Is Independent From Dietary Vitamins E and CArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model.Journal of Clinical Investigation, 1996
- Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteinsCurrent Opinion in Lipidology, 1996
- Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.Journal of Clinical Investigation, 1995
- Susceptibility to in vitro lipid peroxidation of low density lipoproteins and erythrocyte membranes from liver cirrhotic patientsScandinavian Journal of Clinical and Laboratory Investigation, 1994
- Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in manThe Lancet, 1992
- A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart AssociationCirculation, 1975